Tissue microarray methodology identifies complement pathway activation and dysregulation in progressive multiple sclerosis
- 30 July 2017
- journal article
- research article
- Published by Wiley in Brain Pathology
- Vol. 28 (4) , 507-520
Abstract
The complement pathway has potential contributions to both white (WM) and grey matter (GM) pathology in Multiple Sclerosis (MS). A quantitative assessment of complement involvement is lacking. Here we describe the use of Tissue MicroArray (TMA) methodology in conjunction with immunohistochemistry to investigate the localization of complement pathway proteins in progressive MS cortical GM and subcortical WM. Antibodies targeting complement proteins C1q, C3b, regulatory proteins C1 inhibitor (C1INH, complement receptor 1 (CR1), clusterin, factor H (FH) and the C5a anaphylatoxin receptor (C5aR) were utilised alongside standard markers of tissue pathology. All stained slides were digitised for quantitative analysis. We found that numbers of cells immunolabelled for HLA‐DR, GFAP, C5aR, C1q and C3b were increased in WM lesions (WML) and GM lesions (GML) compared to normal appearing WM (NAWM) and GM (NAGM), respectively. The complement regulators C1INH, CR1, FH and clusterin were more abundant in WM lesions, while the number of C1q+ neurons were increased and the number of C1INH+, clusterin+, FH+ and CR1+ neurons decreased in GM lesions. The number of complement component positive cells (C1q, C3b) correlated with complement regulator expression in WM, but there was no statistical association between complement activation and regulator expression in the GM. We conclude that TMA methodology and quantitative analysis provides evidence of complement dysregulation in MS GML, including an association of the numerical density of C1q+ cells with tissue lesions. Our work confirms that complement activation and dysregulation occur in all cases of progressive MS and suggest that complement may provide potential biomarkers of the disease.Keywords
Funding Information
- National Multiple Sclerosis Society Michigan Chapter, Inc. (#993)
This publication has 37 references indexed in Scilit:
- Blockage of CR1 prevents activation of rodent microgliaNeurobiology of Disease, 2013
- Dimerization of complement factor H-related proteins modulates complement activation in vivoProceedings of the National Academy of Sciences, 2013
- Grey matter pathology in clinically early multiple sclerosis: Evidence from magnetic resonance imagingJournal of the Neurological Sciences, 2009
- Immunoglobulins and complement in postmortem multiple sclerosis tissueAnnals of Neurology, 2009
- Gray matter atrophy is related to long-term disability in multiple sclerosisAnnals of Neurology, 2008
- Measurement of Factor H Variants in Plasma Using Variant-Specific Monoclonal Antibodies: Application to Assessing Risk of Age-Related Macular DegenerationInvestigative Ophthalmology & Visual Science, 2008
- Homogeneity of active demyelinating lesions in established multiple sclerosisAnnals of Neurology, 2008
- The Neurobiology of Multiple Sclerosis: Genes, Inflammation, and NeurodegenerationNeuron, 2006
- BLOOD-BRAIN BARRIER DAMAGE IN ACUTE MULTIPLE SCLEROSIS PLAQUESBrain, 1991
- IMMUNOCYTOCHEMICAL LOCALIZATION OF THE TERMINAL COMPLEMENT COMPLEX IN MULTIPLE SCLEROSISNeuropathology and Applied Neurobiology, 1989